These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5490920)

  • 1. The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report.
    Levitt M; DeConti RC; Pearson HA; Marsh JC; Zanes RP; Mitchell MS; Kaetz HW; Bertino JR
    Conn Med; 1970 Dec; 34(12):862-6. PubMed ID: 5490920
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
    Herold M; Anger G; Höche D; Kästner R
    Med Klin (Munich); 1987 May; 82(10):345-9. PubMed ID: 2439886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of Hodgkin's disease with drug combinations].
    Jacquillat C; Weil M; Goguel A; Schaison G; Delobel J; Gemon MF; Brunel-Kotschi R; Teillet F; Boiron M; Bernard J
    Presse Med (1893); 1971 Mar; 79(12):513-8. PubMed ID: 5548259
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance to chemotherapy after prior irradiation for Hodgkin's disease.
    Curran RE; Johnson RE
    Ann Intern Med; 1970 Apr; 72(4):505-9. PubMed ID: 5437632
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical grand rounds. From the Department of Medicine, University of Virginia Medical Center. Hodgkin's disease.
    Va Med Mon (1918); 1974 Jul; 101(7):549-58. PubMed ID: 4847008
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
    Hohaus S; Di Febo A; Storti S; Teofili L; Voso MT; Leone G
    Haematologica; 2004 Jun; 89(6):751-2. PubMed ID: 15194545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of Hodgkin's disease.
    Constable W; Leavell BS
    Va Med Mon (1918); 1970 Jun; 97(6):381-7. PubMed ID: 5006092
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy oif childhood Hodgkin's disease in Uganda.
    Ziegler JL; Fass L; Bluming AZ; Magrath IT; Templeton AC
    Lancet; 1972 Sep; 2(7779):679-82. PubMed ID: 4115819
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
    Isola LM; Cremerius de Sica SM; Palau M; Pereyra MA; Alzugaray AE
    Medicina (B Aires); 1971; 31(2):93-7. PubMed ID: 4935790
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.
    Moore MR; Bull JM; Jones SE; Rosenberg SA; Kaplan HS
    Ann Intern Med; 1972 Jul; 77(1):1-9. PubMed ID: 5052446
    [No Abstract]   [Full Text] [Related]  

  • 13. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R; Haim N; Ben-Shahar M; Valtuch I; Faraggi D; Sharabi-Nov A; Ben-Arie Y; Cohen Y
    Harefuah; 2001 Apr; 140(4):311-5, 367. PubMed ID: 11303395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.
    Miller TP; Jones SE; Rainey JM
    Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200
    [No Abstract]   [Full Text] [Related]  

  • 16. Quadruple chemotherapy in Hodgkin's disease.
    Garrett MJ; Selim HM
    J Ir Med Assoc; 1972 Jan; 65(1):15-9. PubMed ID: 5008706
    [No Abstract]   [Full Text] [Related]  

  • 17. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine and prednisone in previously treated patients with Hodgkin's disease.
    Lowenbraun S; DeVita VT; Serpick AA
    Blood; 1970 Dec; 36(6):704-17. PubMed ID: 5488687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
    Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
    Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin infiltration in Hodgkin's disease.
    Gordon RA; Lookingbill DP; Abt AB
    Arch Dermatol; 1980 Sep; 116(9):1038-40. PubMed ID: 7416756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.